FAQ


Contact Us | LogIn     
Search
1546-2080 Online :: 1546-203X Print
The Patent Eligibility of Graphene Claims Following the U.S. Supreme Court’s Myriad Decision
Volume 10, Issue 2


Authors:
Robert S. Terzoli Jr., Christina N. Gervasi, and Thomas Haag

Abstract:
Graphene has emerged as a promising material for nanotechnology. Dubbed a “wonder material” it has the potential to revolutionize many industries. However, the recent Supreme Court decision in Association for Molecular Pathology v. Myriad Genetics Inc. reversed decades of long standing practice of the USPTO and created a per se rule of patent eligibility regarding DNA that may affect graphene. This article analyzes the relevance of the Myriad case and the distinctions it draws to the patent eligibility of graphene-based inventions.

Full Text (PDF)
Home   :   Aims & Scope    :   Editorial Board    :   Subscriptions   :   Partnerships  :   Disclaimer  :   Contact Us
Nanotechnology Law & Business Copyright 2005